IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria

• Kwan-Ki Hwang,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Ashley M. Trama,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Daniel M. Kozink,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Xi Chen,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Kevin Wiehe,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Abby J. Cooper,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Shi-Mao Xia,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Minyue Wang,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Dawn J. Marshall,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• John Whitesides,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Munir Alam,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Georgia D. Tomaras,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Steven L. Allen,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
• Kanti R. Rai,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
• Jane McKeating,

  Affiliation School of Immunity and Infection, Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Rosa Catera,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
• Xiao-Jie Yan,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
• Charles C. Chu,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
• Garnett Kelsoe,

  Affiliation Department of Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Hua-Xin Liao,

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Nicholas Chiorazzi,

  Affiliation The Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America

  ⨯
•  [ ... ],
• Barton F. Haynes

  * E-mail: hayne002@mc.duke.edu

  Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]